Ruxolitinib (INCB018424) is the first potent, selective, JAK1/2 inhibitor to enter the clinic with IC50 of 3.3 nM/2.8 nM in cell-free assays, >130-fold selectivity for JAK1/2 versus JAK3.
| Quantity | 500 mg, 1 gram |
|---|
Be the first to review “Ruxolitinib”
Related products
New Research Chemicals
$300.00 – $500.00
Powder for Hairloss Treatment Research
$100.00 – $165.00
Sale!
Powder for Hairloss Treatment Research
$300.00 – $4,500.00
Sale!
*New Arrival
$50.00 – $700.00
Sale!
New Research Chemicals
$500.00 – $2,000.00
Sale!
*New Arrival
$355.00 – $1,980.00
*Sales Promotion for 2022
$400.00 – $650.00
*Sales Promotion for 2022
$120.00 – $700.00
Reviews
There are no reviews yet.